Azalive 100Mg Vial
Azalive 100Mg Vial effectively treats some types of blood problems, such as chronic myelomonocytic leukemia. Considered an antineoplastic, Azalive 100Mg Vial prevents the growth and destroys abnormal cells that are found in the bone marrow.
The drug should not be used if you are extremely hypersensitive to a component present in it or are suffering from an advanced stage of liver cancer. Patients with kidney issues as well as other health conditions should discuss the implications of the drug, before using it. Moreover, expecting mothers and those trying to conceive should inform the doctor before Azalive 100Mg Vial treatment begins.
The drug is generally administered through an injection by the doctor. You can also take the injection on your own, once your health care provider has shown you how to do it. Discard Azalive 100Mg Vial if the bottle is cracked or you find any particles in the solution. In case the medicine fall on your skin, wash the affected area immediately. Clean it with plenty of water and soap. In case you happen to miss a dose, get in touch with your medical practitioner.
Is It safe with alcohol?Interaction with alcohol is unknown. Please consult your doctor.
Are there any pregnancy warnings?Azacytin 100mg vial is unsafe to use during pregnancy.
There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Are there any breast-feeding warnings?Azacytin 100mg vial is probably unsafe to use during breastfeeding. Please consult your doctor.
Is it safe to drive while on this medicine?Caution is advised when driving or operating machinery.
Does this affect kidney function?Caution should be advised in patients with renal impairment.
Does this affect liver function?There is no data available. Please consult doctor before consuming the drug.
Azalive 100Mg Vial is used to treat blood/bone marrow disorders. This drug encourages antineoplastic function by blocking DNA methyltransferace at reduced concentration, resulting in DNA hypomethylation and direct cytotoxicity in disputed hematopoietic cells in the bone marrow through its administration into DNA and RNA at high concentration, thereby causing cell death.
Lybrate is a medium to provide our audience with the common information on medicines and does not guarantee its accuracy or exhaustiveness. Even if there is no mention of a warning for any drug or combination, it never means that we are claiming that the drug or combination is safe for consumption without any proper consultation with an expert.
Lybrate does not take responsibility for any aspect of medicines or treatments. If you have any doubts about your medication, we strongly recommend you to see a doctor immediately.